Health
globalreutersSeptember 15, 20241 Mins read
Roche Welcomes FDA Approvals for Injectable Versions of MS and Cancer Drugs
globalreutersSeptember 15, 20241 Mins read 
Roche’s Tecentriq Hybreza is a subcutaneously injectable formulation of the cancer drug Tecentriq while Ocrevus Zunovo is an injectable version of multiple sclerosis drug Ocrevus. Each is administered in minutes compared to an hour or more for infused therapies.
The post Roche Welcomes FDA Approvals for Injectable Versions of MS and Cancer Drugs appeared first on MedCity News.
Recent Posts
Categories
Related Articles
Speculation on RFK Jr. as HHS Secretary
From Tyler Cowen at Marginal Revolution: One of the problems with an...
Family Caregivers Deserve to be a Valued Part of the Healthcare Continuum
Ensuring that family caregivers, and hospice providers all get the support that...
Coping with Winter Depression
Short and cloudy winter days can dwindle your energy, making you sluggish...
Understanding Heart Tumor Treatment in India: A Patient Guide
Dealing with a heart tumor can feel devastating. But, India might offer...
Leave a comment